COVID-19 Africa Watch talks to State Minister Yasmin Wohabrebbi about the policy response to the pandemic, the efforts to develop the digital economy, and the G20 Debt Service Suspension Initiative (DSSI).
“We can count how many amazing things COVID-19 took away from us, and we can also choose to see what COVID-19 has done for us.”
“Better disclosure of the terms of the contracts themselves would certainly be better practice going forward, and in times of stress, it can facilitate quicker and easier engagement with the key multilateral actors.”
As India’s COVID-19 disaster continues to unfold, Africans in the country are facing grim health risks and financial hardships, with uncertain prospects of when they will be able to return home.
COVID-19 Africa Watch talks to Senior Director of the Africa Investment Forum, Chinelo Anohu, about how the COVID-19 pandemic has impacted the AIF’s approach and the overall investment landscape across the continent.
Africa has been identified as a battleground for vaccine diplomacy, where after receiving limited vaccines from western suppliers, countries have recently increasingly looked to China and Russia to bolster inoculation supplies. Feminist human rights practitioner, Mandipa Machacha weighs in on whether this all is a help or a hindrance to the continent.
“What worries me most is that the continent doesn’t get its vaccination program in order in a timely fashion. That means we have to pursue an aggressive process not a passive process.”
Dr. Tlaleng Mofokeng, UN Special Rapporteur on the Right to Health, argues the COVID-19 pandemic has exposed many health systems as inadequately financed, underprepared for managing complex emergencies, and suffering from a lack of agility to respond without threatening the delivery of other health services.
On top of missed income opportunities caused by the freeze of productive activities, many women traders in Zimbabwe suffered economic losses from goods that have remained unsold and, in many cases, gone to waste because of their perishable nature.
In Kenya, the initial rollout of a consignment of 1 million Oxford-AstraZeneca vaccine has faced several hurdles, including fears about safety and concerns about transparency. Stephanie Wangari reports from Nairobi.